| [1] |
Lyon MF. Sex chromatin and gene action in the mammalian X-chromosome[J]. Am J Hum Genet, 1962, 14:135-148.
|
| [2] |
丁秋兰，王学锋，王鸿利，等. 血友病诊断和治疗的专家共识[J]. 临床血液学杂志，2010, 23(1):49-53.
|
| [3] |
Ljung RC. Prenatal diagnosis of haemophilia[J]. Haemophilia, 1999, 5(2):84-87.
|
| [4] |
Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia[J]. Br J Obstet Gynaecol, 1997, 104(7):803-810.
|
| [5] |
Ludlam CA, Pasi KJ, Bolton-Maggs P, et al. A framework for genetic service provision for haemophilia and other inherited bleeding disorders[J]. Haemophilia, 2005, 11(2):145-163.
|
| [6] |
Kadir RA. Women and inherited bleeding disorders: pregnancy and delivery[J]. Semin Hematol, 1999, 36(3 Suppl 4):28-35.
|
| [7] |
Lavery S. Preimplantation genetic diagnosis: new reproductive options for carriers of haemophilia[J]. Haemophilia, 2004, 10(Suppl 4):126-132.
|
| [8] |
Giangrande PL. Management of pregnancy in carriers of haemophilia[J]. Haemophilia, 1998, 4(6):779-784.
|
| [9] |
Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia[J]. Br J Obstet Gynaecol, 1997, 104(7):803-810.
|
| [10] |
Yang MY, Ragni MV. Clinical manifestations and management of labor and delivery in women with factor IX deficiency[J]. Haemophilia, 2004, 10(5):483-490.
|
| [11] |
Ljung R, Lindgren AC, Petrini P, et al. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae[J]. Acta Paediatr, 1994, 83(6):609-611.
|
| [12] |
Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature[J]. J Pediatr Hematol Oncol, 1999, 21(4):289-295.
|
| [13] |
MacLean PE, Fijnvandraat K, Beijlevelt M, et al. The impact of unaware carriership on the clinical presentation of haemophilia[J]. Haemophilia, 2004, 10(5):560-564.
|
| [14] |
Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature[J]. J Pediatr Hematol Oncol, 1999, 21(4):289-295.
|
| [15] |
Chalmers EA. Neonatal coagulation problems[J]. Arch Dis Child Fetal Neonatal Ed, 2004, 89(6):F475-F478.
|
| [16] |
Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia[J]. Br J Haematol, 2001, 112(2):264-274.
|
| [17] |
Kulkarni R, Lusher JM, Henry RC, et al. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council[J]. Haemophilia, 1999, 5(6):410-415.
|
| [18] |
Klinge J, Auberger K, Auerswald G, et al. Prevalence and outcome of intracranial hemorrhage in hemophiliacs-a survey of the paediatric group of the German Society for Thrombosis and Haemostasis (GTH)[J]. Eur J Paediatr, 1999, 158 (Suppl 3):S162-S165.
|
| [19] |
Buchanan GR. Factor concentrate prophylaxis for neonates with hemophilia[J]. J Pediatr Hematol Oncol, 1999, 21(4):254-256.
|
| [20] |
Rodriguez V, Schmidt KA, Slaby JA, et al. Intracranial haemorrhage as initial presentation of severe hemophilia B: case report and review of Mayo Clinic Comprehensive Hemophilia Center experience[J]. Haemophilia, 2005, 11(1):73-77.
|
| [21] |
Lorenzo JI, López A, Altisent C, et al. Incidence of factor Ⅷ inhibitors in severe haemophilia: the importance of patient age[J]. Br J Haematol, 2001, 113(3):600-603.
|
| [22] |
van der Bom JG, Mauser-Bunschoten EP, Fischer K, et al. Age at first treatment and immune tolerance to factor Ⅷ in severe hemophilia[J]. Thromb Haemost, 2003, 89(3):475-479.
|
| [23] |
Rivard GE, Lillicrap D, Poon MC, et al. Can activated recombinant factor Ⅶ be used to postpone the exposure of infants to factor Ⅷ until after 2 years of age？[J]. Haemophilia, 2005, 11(4):335-359.
|
| [24] |
Gilchrist GS, Wilke JL, Muehlenbein LR, et al. Intrauterine correction of factor Ⅷ (FⅧ) deficiency[J]. Haemophilia, 2001, 7(5):497-499.
|
| [25] |
Madoiwa S, Yamauchi T, Hakamata Y, et al. Induction of immune tolerance by neonatal intravenous injection of human factor Ⅷ in murine hemophilia A[J]. J Thromb Haemost, 2004, 2(5):754-762.
|
| [26] |
Russell KE, Olsen EH, Raymer RA, et al. Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs[J]. Blood, 2003, 102(13):4393-4398.
|